First Report of the Clinical Characteristics and Outcomes of Cardiac Amyloidosis in Saudi Arabia
This is the first study to describe the clinical characteristics and outcomes of CA in the Middle East and Saudi Arabia. The prevalence of CA among screened heart failure patients here aligns with major international studies, suggesting significant underdiagnosis in the region. Therefore, larger multicentric studies and regional screening programmes are urgently needed to accurately characterize the epidemiology and outcomes of CA in the Middle East.
Authors
- Hani Alsergani
- Dania Mohty (ORCID: https://orcid.org/0000-0002-7160-2506)
- Ahmed Fathala (ORCID: https://orcid.org/0000-0002-2436-4226)
- Mohamed H. Omer (ORCID: https://orcid.org/0000-0001-5967-9984)
- Islam Alayary
- Bandar Alamro (ORCID: https://orcid.org/0000-0002-8767-0108)
- Thibaud Damy (ORCID: https://orcid.org/0000-0003-4058-3848)
- Bahaa M. Fadel (ORCID: https://orcid.org/0000-0002-1833-3802)
- Omar Ahmad
- Mohammed Janjua
Institutions
- Alfaisal University (SA)
- Pfizer (United States) (US)
- King Faisal Specialist Hospital & Research Centre (SA)
- Assistance Publique – Hôpitaux de Paris (FR)
- Hôpitaux Universitaires Henri-Mondor (FR)
- Cardiff University (GB)
Publication Details
- Journal
- ESC Heart Failure
- Published
- 2024-09-01
- DOI
- https://doi.org/10.1002/ehf2.15045
- Citations
- 4
- Primary Topic
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.94
Funders
- Pfizer